The Cognitive and Research Center of New Jersey, LLC

The Cognitive and Research Center of New Jersey, LLC Bringing you new treatments for Alzheimer's Disease and Memory Loss. Neuropsychological assessments may yield findings not observable using other techniques.

The Cognitive and Research Center of New Jersey Clinical Trials for Dementia and Memory Impairment. Results of the evaluation may be used for clinical, planning, application, or other processes. The information obtained by a neuropsychological evaluation can be instrumental in helping the patient and family
understand and cope better with existing behaviors and symptoms. Clinical Trials:
A clinical trial is a research study in which qualifying
volunteers participate in a protocol where
experimental treatments are tested. At CRCNJ, we
are conducting numerous trials, sponsored by
different pharmaceutical companies, aimed at
treating memory impairment and Alzheimer’s
disease. For more information about trials for which
we are currently enrolling, please call us or visit our
website. Each trial is unique in terms of eligibility
for enrollment, study drug, time commitment, and
schedule of assessments. We would be happy to
help you find a trial that would be appropriate
for you. Psychotherapy:
Before you decide whether or not psychotherapy
is for you, get the facts. Here are just some of the
advantages and outcomes of psychotherapy:
■ Improved relationships
■ Increased self-esteem
and self- confidence
■ Sense of empowerment
■ Improved
problem-solving
■ Reduced stress
■ Increased healthfulness
■ Better understanding of oneself
■ Clarity of past, present, and future
■ Development of tolerance for self and others
■ Increased awareness and control of behaviors
■ Recognition of all possibilities
■ Increased realization of opportunities
■ Sense of peacefulness

03/02/2026

During , we’re honoring the trailblazing women who have put their voices and hearts behind the fight to end Alzheimer’s.💜

Long before she was personally affected, Pauline Phillips — known to millions as Dear Abby — changed the conversation around Alzheimer’s. In 1980, she published a letter from a woman whose 60-year-old husband had just been diagnosed. At a time when few were talking openly about Alzheimer’s or other dementia, she met that fear with clarity and compassion.

Her message was simple and powerful: You are not alone. She directed readers to the newly formed Alzheimer’s Association — and within two weeks, more than 22,000 letters poured in from families seeking help.

Pauline reminded families that support exists and that no one should face this disease in silence. In her honor — and in honor of all the women who lead with courage and heart — we continue the fight to .

02/28/2026

This Black History Month, we honor Dr. Solomon Carter Fuller (1872–1953), a pioneering neuropathologist and one of the first researchers in Alzheimer’s disease. Dr. Fuller became the first black psychiatrist in the United States.

At a time when both racial barriers and scientific understanding in his field was limited, Dr. Fuller helped lay the groundwork for how we study and care for age-related brain disease. His research advanced early knowledge of Alzheimer’s and shaped the future of dementia care in the United States.

Solomon Fuller was born in Monrovia, Liberia, to parents of African-American descent. His paternal grandparents, John Lewis Fuller and his wife, had been slaves in Virginia. John Fuller bought his and his enslaved wife's freedom and they moved to Norfolk, Virginia.

He completed his medical degree in 1897 from Boston University School of Medicine. He then went to the Royal Psychiatric Hospital at the University of Munich, Germany, conducting research under Emil Kraepelin and Alois Alzheimer. During that time, Fuller performed ground-breaking research on the physical changes that occur in the brains of Alzheimer's disease patients.

Before Alzheimer’s was widely understood, Dr. Solomon Carter Fuller was working to advance research that would change how we care for older adults.

02/25/2026

People who drank the most caffeinated coffee had a lower risk of dementia compared with those who drank the least, the long-term observational study found.

02/09/2026
02/03/2026

Did you know that your ❤️ and 🧠 are connected? Many heart-healthy habits are also brain-healthy habits! When you engage in regular exercise, control your blood pressure, and maintain a healthy weight, you can reduce your risk of cognitive decline and dementia. Learn more healthy habits for your brain at alz.org/healthyhabits.

01/28/2026

In a new study, the vaccine was tied to lower risk of MCI and dementia-related death, hinting it may influence disease progression.

01/23/2026

Wandering is a common and potentially dangerous behavior among individuals living with dementia.  January 21, 2026 – Arctic blasts and polar vortexes are causing dangerously cold, frigid conditions in areas […]

01/21/2026

Research suggests that Alzheimer’s disease progression may be linked to lack of deep sleep, but it’s never too late to improve sleep quality.

This Tuesday! Registration is free for all attendees.
01/15/2026

This Tuesday! Registration is free for all attendees.

Address

195 Mountain Avenue
Springfield, NJ
07081

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 4:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Alerts

Be the first to know and let us send you an email when The Cognitive and Research Center of New Jersey, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Cognitive and Research Center of New Jersey, LLC:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category